Development of written information for antiretroviral therapy: comprehension in a Tanzanian population
- 174 Downloads
To design and develop a simple, easily readable patient information leaflet (PIL) for a commonly used antiretroviral (ARV) regimen and to evaluate its readability and acceptability in a Tanzanian population.
A PIL incorporating simple text and pictograms was designed for the antiretroviral regimen of stavudine, lamivudine and efavirenz. The PIL was designed according to established good design guidelines, modified during a multi-stage iterative testing process and piloted in a South African Xhosa population. The PIL was made available in both English and Kiswahili. Sixty Tanzanian participants who were not taking ARVs were interviewed. They were asked to read the PIL in the language of their choice and were then asked a series of two-part questions; the first part required participants to locate the information in the PIL, after which they were asked to explain the information in their own words. Acceptability was assessed through close-ended questions and open-ended feedback. The influence of selected patient characteristics on comprehension of the PIL was investigated using one-way ANOVA and t-tests for independent samples with a significance level set at 0.05.
Main outcome measure
Comprehension of the written information in an overall percentage understanding.
The overall average percentage comprehension of the PIL was 95%. The target set by the EC guideline that at least 80% of participants correctly locate and understand the information was achieved for 19 of the 20 questions. Five of the six instructions illustrated by pictograms were correctly understood by all participants. The only patient characteristics significantly associated with comprehension were educational level and self-reported ease of reading the PIL. Acceptability of the PIL was high and positive comments were associated with simplicity, good design, easy readability and user-friendliness, the latter enhanced by the inclusion of pictograms.
The PIL designed for this study was shown to be effective in communicating information about ARVs. Patient characteristics must be taken into account when developing written information, and the final document must be tested for comprehension in the target population.
KeywordsAcceptability Antiretrovirals Comprehension Patient communication Patient information leaflet Pictograms PIL Tanzania Written information
The authors would like to thank Professor Sarah Radloff for her help with the statistics, and the interpreter and participants who contributed to this project.
Financial support of the study Financial support from Rhodes University and Wyeth South Africa is gratefully acknowledged.
- 2.Howard J., Wildman K., Blain J., Wills S., Brown D. The importance of drug information from a patient perspective. J Soc Admin Pharm 1999; 16:115–26.Google Scholar
- 8.Doak CC, Doak LG, Root JH. Teaching patients with low-literacy skills. Philadelphia (JB): Lippincott Co; 1996. ISBN 0-397-55161-4Google Scholar
- 9.Morris LA, Aikin KJ. The pharmacokinetics of patient communications. Drug Inf J 2001; 35:509–27.Google Scholar
- 12.Davis TC, Mayeaux EJ, Fredrickson D, Bocchini JA, Jackson RH, Murphy PW. Reading ability of parents compared with reading level of pediatric patient education materials. Pediatrics 1994; 98:460–4.Google Scholar
- 13.Institute of Medicine Committee on Health Literacy. Health literacy: a prescription to end confusion. Washington, DC: The National Academies Press; 2004. ISBN 0-309-52926-3Google Scholar
- 16.UNESCO Institute for Statistics, Literacy Statistics (August 2005 assessment). http://www.uis.unesco.org/ev.php?URL_ID=5204&URL_DO=DO_TOPIC&URL_SECTION=201(November 17, 2005)Google Scholar
- 17.UNAIDS/WHO AIDS epidemic update: December 2005. http://www.unaids.org/Epi2005/doc/report_pdf.html (November 23,2005)
- 18.Tanzania Care. HIV/AIDS in Tanzania. (Fact sheet) October 2005. http://tanzaniacare.org/download/fact_sheets/AIDS_in_Tanzania.pdf 4 (November 21, 2005)
- 19.Smith SR, Rublein JC, Marcus C, Penick Brock T, Chesney MA. A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns 2003; 50:187–99.Google Scholar
- 20.Sless D, Wiseman R. Writing about medicines for people, 2nd ed. Australian Government Publishing Service: Canberra; 1997.Google Scholar
- 23.Raynor DK. Writing patient information—A pharmacist’s guide. Pharm J 1992; 249:180–2.Google Scholar
- 24.Medicines Control Council, Department of Health, Republic of South Africa. Guidelines on the requirements for patient information leaflets. Document 2.14MAY04V2:May 2004Google Scholar
- 25.USP DI. Vol. II 2000. Advice for the patient. Drug information in lay language. 20th ed. Englewood: Micromedex, Inc.; 2000Google Scholar
- 27.Mwingira B. Written medicines information for antiretroviral therapy. [MSc Dissertation]. Grahamstown: B Mwingira; 2005Google Scholar
- 28.Fry E. Fry’s readability graph: Clarification, validity, and extension to level 17. J Reading 1977; 21:242–52.Google Scholar
- 29.Sojourner R, Wogalter M. The influence of pictorials on the comprehension and recall of pharmaceutical safety and warning information. Int J Cogn Ergon 1998; 2:93–106.Google Scholar